Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly (LLY) and Novo Nordisk (NVO) stock.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma ...

The ₹8,500 crore order from Eli Lilly and Company is a testament to Remedium Lifecares capabilities and its growing ...

Remedium Lifecare is well-positioned to capitalize on the opportunities presented by this landmark deal.

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet ...

Colulintide is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) ...

LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success ...

Eli Lilly (LLY) has been one of the most ... During this period, the Zacks Large Cap Pharmaceuticals industry, which Lilly falls in, has lost 5.7%. The key question now is: What could be the ...

The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.